C149H185N41O18S3 — CID 160786512
3-[[2-[4-(4-hydroxypiperidin-1-yl)-2-methoxyanilino]-7H-purin-6-yl]amino]-N-methylbenzamide;3-[[2-[4-(4-hydroxypiperidin-1-yl)-2-methoxyanilino]-7H-purin-6-yl]amino]-N-(oxan-4-yl)benzamide;[3-methoxy-4-[[6-(2-propan-2-ylsulfonylanilino)-7H-purin-2-yl]amino]phenyl]-(4-piperidin-1-ylpiperidin-1-yl)methanone;2-N-[5-methyl-4-(4-methylpiperazin-1-yl)-2-propan-2-yloxyphenyl]-6-N-(2-propan-2-ylsulfonylphenyl)-7H-purine-2,6-diamine;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[3-propan-2-yloxy-4-[[6-(2-propan-2-ylsulfonylanilino)-7H-purin-2-yl]amino]phenyl]methanone (PubChem CID 160786512) has the molecular formula C149H185N41O18S3 and a molecular weight of 2934.59 g/mol. Its IUPAC name is 3-[[2-[4-(4-hydroxypiperidin-1-yl)-2-methoxyanilino]-7H-purin-6-yl]amino]-N-methylbenzamide;3-[[2-[4-(4-hydroxypiperidin-1-yl)-2-methoxyanilino]-7H-purin-6-yl]amino]-N-(oxan-4-yl)benzamide;[3-methoxy-4-[[6-(2-propan-2-ylsulfonylanilino)-7H-purin-2-yl]amino]phenyl]-(4-piperidin-1-ylpiperidin-1-yl)methanone;2-N-[5-methyl-4-(4-methylpiperazin-1-yl)-2-propan-2-yloxyphenyl]-6-N-(2-propan-2-ylsulfonylphenyl)-7H-purine-2,6-diamine;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[3-propan-2-yloxy-4-[[6-(2-propan-2-ylsulfonylanilino)-7H-purin-2-yl]amino]phenyl]methanone.
| Compound Name | 3-[[2-[4-(4-hydroxypiperidin-1-yl)-2-methoxyanilino]-7H-purin-6-yl]amino]-N-methylbenzamide;3-[[2-[4-(4-hydroxypiperidin-1-yl)-2-methoxyanilino]-7H-purin-6-yl]amino]-N-(oxan-4-yl)benzamide;[3-methoxy-4-[[6-(2-propan-2-ylsulfonylanilino)-7H-purin-2-yl]amino]phenyl]-(4-piperidin-1-ylpiperidin-1-yl)methanone;2-N-[5-methyl-4-(4-methylpiperazin-1-yl)-2-propan-2-yloxyphenyl]-6-N-(2-propan-2-ylsulfonylphenyl)-7H-purine-2,6-diamine;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[3-propan-2-yloxy-4-[[6-(2-propan-2-ylsulfonylanilino)-7H-purin-2-yl]amino]phenyl]methanone |
|---|---|
| PubChem CID | 160786512 |
| Molecular Formula | C149H185N41O18S3 |
| Molecular Weight | 2934.59 g/mol |
| Exact Mass | 2932.40 |
| IUPAC Name | 3-[[2-[4-(4-hydroxypiperidin-1-yl)-2-methoxyanilino]-7H-purin-6-yl]amino]-N-methylbenzamide;3-[[2-[4-(4-hydroxypiperidin-1-yl)-2-methoxyanilino]-7H-purin-6-yl]amino]-N-(oxan-4-yl)benzamide;[3-methoxy-4-[[6-(2-propan-2-ylsulfonylanilino)-7H-purin-2-yl]amino]phenyl]-(4-piperidin-1-ylpiperidin-1-yl)methanone;2-N-[5-methyl-4-(4-methylpiperazin-1-yl)-2-propan-2-yloxyphenyl]-6-N-(2-propan-2-ylsulfonylphenyl)-7H-purine-2,6-diamine;[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-[3-propan-2-yloxy-4-[[6-(2-propan-2-ylsulfonylanilino)-7H-purin-2-yl]amino]phenyl]methanone |
| SMILES | CC(C)Oc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1nc(Nc2ccccc2S(=O)(=O)C(C)C)c2[nH]cnc2n1.CNC(=O)c1cccc(Nc2nc(Nc3ccc(N4CCC(O)CC4)cc3OC)nc3nc[nH]c23)c1.COc1cc(C(=O)N2CCC(N3CCCCC3)CC2)ccc1Nc1nc(Nc2ccccc2S(=O)(=O)C(C)C)c2[nH]cnc2n1.COc1cc(N2CCC(O)CC2)ccc1Nc1nc(Nc2cccc(C(=O)NC3CCOCC3)c2)c2[nH]cnc2n1.Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3[nH]cnc3n2)c(OC(C)C)cc1N1CCN(C)CC1 |
| InChI | InChI=1S/C34H45N9O4S.C32H40N8O4S.C29H34N8O4.C29H38N8O3S.C25H28N8O3/c1-22(2)47-28-20-24(33(44)43-14-12-25(13-15-43)42-18-16-41(5)17-19-42)10-11-26(28)38-34-39-31-30(35-21-36-31)32(40-34)37-27-8-6-7-9-29(27)48(45,46)23(3)4;1-21(2)45(42,43)27-10-6-5-9-25(27)35-30-28-29(34-20-33-28)37-32(38-30)36-24-12-11-22(19-26(24)44-3)31(41)40-17-13-23(14-18-40)39-15-7-4-8-16-39;1-40-24-16-21(37-11-7-22(38)8-12-37)5-6-23(24)34-29-35-26-25(30-17-31-26)27(36-29)32-20-4-2-3-18(15-20)28(39)33-19-9-13-41-14-10-19;1-18(2)40-24-16-23(37-13-11-36(6)12-14-37)20(5)15-22(24)33-29-34-27-26(30-17-31-27)28(35-29)32-21-9-7-8-10-25(21)41(38,39)19(3)4;1-26-24(35)15-4-3-5-16(12-15)29-23-21-22(28-14-27-21)31-25(32-23)30-19-7-6-17(13-20(19)36-2)33-10-8-18(34)9-11-33/h6-11,20-23,25H,12-19H2,1-5H3,(H3,35,36,37,38,39,40);5-6,9-12,19-21,23H,4,7-8,13-18H2,1-3H3,(H3,33,34,35,36,37,38);2-6,15-17,19,22,38H,7-14H2,1H3,(H,33,39)(H3,30,31,32,34,35,36);7-10,15-19H,11-14H2,1-6H3,(H3,30,31,32,33,34,35);3-7,12-14,18,34H,8-11H2,1-2H3,(H,26,35)(H3,27,28,29,30,31,32) |
| InChIKey | SBGXTVQLLMOOHE-UHFFFAOYSA-N |
| XLogP | 21.54 |
| TPSA | 712.36 Ų |
| H-Bond Donors | 19 |
| H-Bond Acceptors | 50 |
| Rotatable Bonds | 43 |
| Heavy Atoms | 211 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2934.59 |
| LogP ≤ 5 | 21.54 |
| H-Bond Donors ≤ 5 | 19 |
| H-Bond Acceptors ≤ 10 | 50 |